Adjuvant oncology treatment comprises
of a class of cancer therapeutics which is followed after primary cancer
treatment, to minimize the risk of reoccurrence of cancer. The major
forms of adjuvant therapy are radiation therapy, chemotherapy, hormone
therapy, biological therapy, and targeted therapy. Before deciding the
adjuvant therapy to be used, statistical evidence is used by oncologists
for the assessment of risk of disease relapse.
Increase in prevalence of cancer,
growing reimbursement initiatives by governments and insurance companies
covering treatment for cancer and growth in preference for the future
prevention of cancer are some of the major drivers of this market.
Growth in research initiatives in increasing the scope of the diseases
which could be treated with adjuvant therapy serve as the prime
opportunity for the future growth of this market.
To Read The Complete Report with TOC : http://www.marketresearchreports.biz/analysis-details/adjuvants-market-global-industry-analysis-size-share-growth-trends-and-forecast-2012-2018
The major aim of giving adjuvant
therapy to cancer patients is to increase the chance of overall survival
of such patient. Since the rationale behind adjuvant therapy is
elimination of future risk, the accepted rule is that the patients were
already cured via primary surgical treatment. Thus, such therapies given
after an oncological surgery for different types of cancers such as
that of lung, breast, colon, prostate, and various forms of
gynecological cancers. Adjuvant therapy is often given after oncology
surgery the treatment procedure of illnesses such as colon cancer,
pancreatic cancer, gynecological cancer, breast cancer, lung cancer, and
prostate cancer. However, some forms of cancer such as renal carcinoma
and some types of brain cancer have failed to benefit from such a
therapy.
The overall market for oncology
adjuvants is classified on the basis of applications of adjuvants such
as chemotherapy, radiotherapy, immunotherapy and others. On the basis of
diseases which are treated through adjuvants, this market is classified
into breast cancer, colorectal cancer, sarcoma, Hodgkin’s lymphoma,
glioblastoma, lung cancer, prostate cancer, and ovarian cancer.
Some of the market players in this
industry include pharmaceutical manufacturers such as Amgen, Inc., Eli
Lilly Co., BMS, Biogen, AstraZeneca PLC, Sanofi, Pfizer, Inc. and
others.
This research report analyzes this
market depending on its market segments, major geographies, and current
market trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Europe
- Rest of the World
This report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of
current trends in the market, industry growth drivers, and restraints.
It provides market projections for the coming years. It includes
analysis of recent developments in technology, Porter’s five force model
analysis and detailed profiles of top industry players. The report also
includes a review of micro and macro factors essential for the existing
market players and new entrants along with detailed value chain
analysis.
Reasons for Buying this Report
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a technological growth map over time to understand the industry growth rate
- It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
- It provides distinctive graphics and exemplified SWOT analysis of major market segments
About Us
MarketResearchReports.Biz is the
most comprehensive collection of market research reports.
MarketResearchReports.Biz services are especially designed to save time and
money of our clients. We are a one stop solution for all your research needs,
our main offerings are syndicated research reports, custom research,
subscription access and consulting services. We serve all sizes and types of
companies spanning across various industries.
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
No comments:
Post a Comment